168 related articles for article (PubMed ID: 24196439)
1. CDK6 binds and promotes the degradation of the EYA2 protein.
Kohrt D; Crary J; Zimmer M; Patrick AN; Ford HL; Hinds PW; Grossel MJ
Cell Cycle; 2014; 13(1):62-71. PubMed ID: 24196439
[TBL] [Abstract][Full Text] [Related]
2. miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.
Fu J; Xu X; Kang L; Zhou L; Wang S; Lu J; Cheng L; Fan Z; Yuan B; Tian P; Zheng X; Yu C; Ye Q; Lv Z
Biochem Biophys Res Commun; 2014 Mar; 445(2):314-9. PubMed ID: 24508260
[TBL] [Abstract][Full Text] [Related]
3. Eya2 overexpression promotes the invasion of human astrocytoma through the regulation of ERK/MMP9 signaling.
Wen Z; Liang C; Pan Q; Wang Y
Int J Mol Med; 2017 Nov; 40(5):1315-1322. PubMed ID: 28901379
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells.
Meziane el K; Randle SJ; Nelson DE; Lomonosov M; Laman H
J Cell Sci; 2011 Jul; 124(Pt 13):2175-86. PubMed ID: 21652635
[TBL] [Abstract][Full Text] [Related]
5. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
[TBL] [Abstract][Full Text] [Related]
6. Eya2 expression during mouse embryonic development revealed by Eya2
Zhang T; Xu J; Xu PX
Dev Dyn; 2021 Oct; 250(10):1450-1462. PubMed ID: 33715274
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
Yan H; Ren S; Lin Q; Yu Y; Chen C; Hua X; Jin H; Lu Y; Zhang H; Xie Q; Huang C; Huang H
FASEB J; 2019 Nov; 33(11):12112-12123. PubMed ID: 31373842
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Cdk6 and Ccnd1 in chondrocytes inhibited chondrocyte maturation and caused p53-dependent apoptosis without enhancing proliferation.
Ito K; Maruyama Z; Sakai A; Izumi S; Moriishi T; Yoshida CA; Miyazaki T; Komori H; Takada K; Kawaguchi H; Komori T
Oncogene; 2014 Apr; 33(14):1862-71. PubMed ID: 23624920
[TBL] [Abstract][Full Text] [Related]
9. Aberrant hypomethylation and overexpression of the eyes absent homologue 2 suppresses tumor cell growth of human lung adenocarcinoma cells.
Gao T; Zheng S; Li Q; Ran P; Sun L; Yuan Y; Xiao C
Oncol Rep; 2015 Nov; 34(5):2333-42. PubMed ID: 26329363
[TBL] [Abstract][Full Text] [Related]
10. Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy.
Lee SH; Kim J; Ryu JY; Lee S; Yang DK; Jeong D; Kim J; Lee SH; Kim JM; Hajjar RJ; Park WJ
J Mol Cell Cardiol; 2012 Mar; 52(3):718-26. PubMed ID: 22197309
[TBL] [Abstract][Full Text] [Related]
11. Changes in motility, gene expression and actin dynamics: Cdk6-induced cytoskeletal changes associated with differentiation in mouse astrocytes.
Slomiany P; Baker T; Elliott ER; Grossel MJ
J Cell Biochem; 2006 Oct; 99(2):635-46. PubMed ID: 16767702
[TBL] [Abstract][Full Text] [Related]
12. The Eyes Absent Proteins: Unusual HAD Family Tyrosine Phosphatases.
Roychoudhury K; Hegde RS
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920226
[TBL] [Abstract][Full Text] [Related]
13. Eya2 promotes cell cycle progression by regulating DNA damage response during vertebrate limb regeneration.
Sousounis K; Bryant DM; Martinez Fernandez J; Eddy SS; Tsai SL; Gundberg GC; Han J; Courtemanche K; Levin M; Whited JL
Elife; 2020 Mar; 9():. PubMed ID: 32142407
[TBL] [Abstract][Full Text] [Related]
14. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells.
Feng L; Xie Y; Zhang H; Wu Y
Med Oncol; 2012 Jun; 29(2):856-63. PubMed ID: 21264532
[TBL] [Abstract][Full Text] [Related]
15. Eya2 is critical for the E2A‑HLF‑mediated immortalization of mouse hematopoietic stem/progenitor cells.
Maharjan BD; Ono R; Nosaka T
Int J Oncol; 2019 Mar; 54(3):981-990. PubMed ID: 30628662
[TBL] [Abstract][Full Text] [Related]
16. From cell cycle to differentiation: an expanding role for cdk6.
Grossel MJ; Hinds PW
Cell Cycle; 2006 Feb; 5(3):266-70. PubMed ID: 16410727
[TBL] [Abstract][Full Text] [Related]
17. CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle.
Fan Y; Li H; Liang X; Xiang Z
Oncotarget; 2017 Mar; 8(12):19934-19946. PubMed ID: 28193906
[TBL] [Abstract][Full Text] [Related]
18. Eya2, a Target Activated by Plzf, Is Critical for
Ono R; Masuya M; Ishii S; Katayama N; Nosaka T
Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416638
[TBL] [Abstract][Full Text] [Related]
19. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
20. Distinct subcellular distribution of cyclin dependent kinase 6.
Kohrt DM; Crary JI; Gocheva V; Hinds PW; Grossel MJ
Cell Cycle; 2009 Sep; 8(17):2837-43. PubMed ID: 19667758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]